KALA BIO, INC. Derivative Liability, Number of Instruments Held
KALA BIO, INC. (KALA) had Derivative Liability, Number of Instruments Held of 1 item as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes
us-gaap:DerivativeLiabilityNumberOfInstrumentsHeld · last filed 2025-03-31
- 2024-12-31: Derivative Liability, Number of Instruments Held 1.00 item.
- 2023-12-31: Derivative Liability, Number of Instruments Held 1.00 item.
- 2018-10-01: Derivative Liability, Number of Instruments Held 1.00 item.
| Period end | Derivative Liability, Number of Instruments Held |
|---|---|
| 2024-12-31 | 1.00 item 10-K · filed 2025-03-31 |
| 2023-12-31 | 1.00 item 10-K · filed 2024-03-29 |
| 2018-10-01 | 1.00 item 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |